Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. It offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. The company was founded in 2010 and is headquartered in Taizhou, China.
Stock data | 2024 | Change |
---|---|---|
Price | $9.01 | N/A |
Market Cap | $527.98M | N/A |
Shares Outstanding | 58.62M | N/A |
Employees | 1.08K | N/A |